Jump to content
RemedySpot.com

US panel rejects & leukemia pill/Reuters

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 05

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

Thu May 5, 2005 02:45 PM ET

ROCKVILLE, Md., May 5 (Reuters) - A U.S. advisory panel on Thursday rejected

& 's (JNJ.N: Quote, Profile, Research) pill Zarnestra for

treating elderly leukemia patients who have only months to live and are poor

candidates for chemotherapy.

The Food and Drug Administration panel voted 7-4 that Zarnestra should not

be sold for treating older patients newly diagnosed with acute myeloid

leukemia, or AML, who are too frail for chemotherapy and unlikely to benefit

from it. The FDA usually follows its panels' advice.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...